The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Mitochondria as targets for cancer chemotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432
Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4
Scherz‐Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., & Elazar, Z. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601623 · Cited by 2,101 · cited 2×
“A target for H2O2 was the cysteine protease HsAtg4, particuarly, a cysteine residue located near the HsAtg4 catalytic site [40].”
BackgroundTIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Mathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468
Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes
Shimizu, S., Kanaseki, T., Mizushima, N., Mizuta, T., Arakawa-Kobayashi, S., Thompson, C. B., & Tsujimoto, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1192 · Cited by 1,358
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904
Guzy, R. D., & Schumacker, P. T. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033506 · Cited by 881
Lemasters, J. J., Qian, T., He, L., Kim, J.-S., Elmore, S. P., Cascio, W. E., & Brenner, D. A. (2002) · Antioxidants & Redox Signaling · doi:10.1089/152308602760598918 · Cited by 377
Abu-Hamad, S., Zaid, H., Israelson, A., Nahon, E., & Shoshan-Barmatz, V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708216200 · Cited by 278 · cited 2×
“This observation, however, is in contrast with the report that HK-I, which binds to VDAC and causes its closure, inhibits cytochrome c release and protects against apoptotic cell death [86].”
ResultZhao, Y., Chaiswing, L., Velez, J. M., Batinic-Haberle, I., Colburn, N. H., Oberley, T. D., & St. Clair, D. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3835 · Cited by 245
Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved
López-Lázaro, M. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.8.1043 · Cited by 145
Research works printed but not linked: 96
- Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
- Simonnet, 2002, Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma, Carcinogenesis, 23, 759, 10.1093/carcin/23.5.759 · DOI · Paper page
- Nakashima, 1984, Contributions of glycolysis and oxidative phosphorylation to adenosine 5’-triphosphate production in AS-30D hepatoma cells, Cancer Res, 44, 5702
- Weinhouse, 1976, The Warburg hypothesis fifty years later, Z Krebsforsch Klin Onkol Cancer Res Clin Oncol, 87, 115, 10.1007/BF00284370 · DOI · Paper page
- Hammond, 2005, The role of p53 in hypoxia-induced apoptosis, Biochem Biophys Res Commun, 331, 718, 10.1016/j.bbrc.2005.03.154 · DOI · Paper page
- Moll, 1998, Schramm LM. p53--an acrobat in tumorigenesis, Crit Rev Oral Biol Med, 9, 23, 10.1177/10454411980090010101 · DOI
- Semenza, 1996, Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1, J Biol Chem, 271, 32529, 10.1074/jbc.271.51.32529 · DOI · Paper page
- Wang, 1976, Aerobic glycolysis during lymphocyte proliferation, Nature, 261, 702, 10.1038/261702a0 · DOI · Paper page
- Ibsen, 1961, The Crabtree effect: a review, Cancer Res, 21, 829
- Guppy, 1993, The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes, Eur J Biochem, 212, 95, 10.1111/j.1432-1033.1993.tb17637.x · DOI · Paper page
- Wojtczak, 1999, Effect of glucose and deoxyglucose on the redistribution of calcium in ehrlich ascites tumour and Zajdela hepatoma cells and its consequences for mitochondrial energetics. Further arguments for the role of Ca(2+) in the mechanism of the crabtree effect, Eur J Biochem, 263, 495, 10.1046/j.1432-1327.1999.00522.x · DOI
- Lopez-Rios, 2007, Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas, Cancer Res, 67, 9013, 10.1158/0008-5472.CAN-07-1678 · DOI · Paper page
- Pelicano, 2004, ROS stress in cancer cells and therapeutic implications, Drug Resist Updat, 7, 97, 10.1016/j.drup.2004.01.004 · DOI · Paper page
- Storz, 2005, Reactive oxygen species in tumor progression, Front Biosci, 10, 1881, 10.2741/1667 · DOI · Paper page
- Polyak, 1998, Somatic mutations of the mitochondrial genome in human colorectal tumours, Nat Genet, 20, 291, 10.1038/3108 · DOI · Paper page
- Brand, 2004, Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins, Free Radic Biol Med, 37, 755, 10.1016/j.freeradbiomed.2004.05.034 · DOI · Paper page
- Derdak, 2008, The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells, Cancer Res, 68, 2813, 10.1158/0008-5472.CAN-08-0053 · DOI · Paper page
- Fang, 2007, Tumor-targeted induction of oxystress for cancer therapy, J Drug Target, 15, 475, 10.1080/10611860701498286 · DOI · Paper page
- Kong, 1998, Antioxidant inhibitors for cancer therapy, Med Hypotheses, 51, 405, 10.1016/S0306-9877(98)90036-6 · DOI
- Huang, 2000, Superoxide dismutase as a target for the selective killing of cancer cells, Nature, 407, 390, 10.1038/35030140 · DOI · Paper page
- Engel, 2006, Oxidative stress and apoptosis: a new treatment paradigm in cancer, Front Biosci, 11, 300, 10.2741/1798 · DOI · Paper page
- Kerr, 1972, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer, 26, 239, 10.1038/bjc.1972.33 · DOI · Paper page
- Orrenius, 2003, Regulation of cell death: the calcium-apoptosis link, Nat Rev Mol Cell Biol, 4, 552, 10.1038/nrm1150 · DOI · Paper page
- Proskuryakov, 2003, Necrosis: a specific form of programmed cell death?, Exp Cell Res, 283, 1, 10.1016/S0014-4827(02)00027-7 · DOI · Paper page
- Kitanaka, 1999, Caspase-independent programmed cell death with necrotic morphology, Cell Death Differ, 6, 508, 10.1038/sj.cdd.4400526 · DOI · Paper page
- Morgan, 2008, TNFalpha and reactive oxygen species in necrotic cell death, Cell Res, 18, 343, 10.1038/cr.2008.31 · DOI · Paper page
- Boujrad, 2007, AIF-mediated programmed necrosis: a highly regulated way to die, Cell Cycle, 6, 2612, 10.4161/cc.6.21.4842 · DOI · Paper page
- Gozuacik, 2004, Autophagy as a cell death and tumor suppressor mechanism, Oncogene, 23, 2891, 10.1038/sj.onc.1207521 · DOI · Paper page
- Moretti, 2007, Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy, Drug Resist Updat, 10, 135, 10.1016/j.drup.2007.05.001 · DOI
- Hippert, 2006, Autophagy in cancer: good, bad, or both?, Cancer Res, 66, 9349, 10.1158/0008-5472.CAN-06-1597 · DOI · Paper page
- Karantza-Wadsworth, 2007, Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis, Genes Dev, 21, 1621, 10.1101/gad.1565707 · DOI · Paper page
- Kim, 2008, Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer, Autophagy, 4, 659, 10.4161/auto.6058 · DOI · Paper page
- Bras, 2005, Programmed cell death via mitochondria: different modes of dying, Biochemistry (Mosc), 70, 231, 10.1007/s10541-005-0105-4 · DOI · Paper page
- Tsujimoto, 1987, Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma, Oncogene, 2, 3
- Tsujimoto, 2000, Bcl-2 family: life-or-death switch, FEBS Lett, 466, 6, 10.1016/S0014-5793(99)01761-5 · DOI · Paper page
- Hockenbery, 1990, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348, 334, 10.1038/348334a0 · DOI · Paper page
- Hennet, 1993, Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity, Cancer Res, 53, 1456
- Festjens, 2004, Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death, Acta Haematol, 111, 7, 10.1159/000074483 · DOI
- Cory, 2003, The Bcl-2 family: roles in cell survival and oncogenesis, Oncogene, 22, 8590, 10.1038/sj.onc.1207102 · DOI · Paper page
- Wei, 2001, Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death, Science, 292, 727, 10.1126/science.1059108 · DOI · Paper page
- Abel, 2005, Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology, Eur J Cancer, 41, 635, 10.1016/j.ejca.2004.12.021 · doi:10.1016/j.ejca.2004.12.021
- Hunter, 1979, The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms, Arch Biochem Biophys, 195, 453, 10.1016/0003-9861(79)90371-0 · DOI · Paper page
- Crompton, 2000, Mitochondrial intermembrane junctional complexes and their role in cell death, J Physiol, 529, 11, 10.1111/j.1469-7793.2000.00011.x · DOI · Paper page
- Leung, 2008, Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore, Biochim Biophys Acta, 1777, 946, 10.1016/j.bbabio.2008.03.009 · DOI · Paper page
- Evtodienko, 1999, The Ca2+ threshold for the mitochondrial permeability transition and the content of proteins related to Bcl-2 in rat liver and Zajdela hepatoma mitochondria, Mol Cell Biochem, 194, 251, 10.1023/A:1006913526643 · DOI
- Kinnally, 2007, A tale of two mitochondrial channels, MAC and PTP, in apoptosis, Apoptosis, 12, 857, 10.1007/s10495-007-0722-z · DOI · Paper page
- Pavlov, 2001, A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast, J Cell Biol, 155, 725, 10.1083/jcb.200107057 · DOI · Paper page
- Ott, 2002, Cytochrome c release from mitochondria proceeds by a two-step process, Proc Natl Acad Sci U S A, 99, 1259, 10.1073/pnas.241655498 · DOI · Paper page
- Orrenius, 2007, Mitochondrial oxidative stress: implications for cell death, Annu Rev Pharmacol Toxicol, 47, 143, 10.1146/annurev.pharmtox.47.120505.105122 · DOI · Paper page
- Scatena, 2008, Glycolytic enzyme inhibitors in cancer treatment, Expert Opin Investig Drugs, 17, 1533, 10.1517/13543784.17.10.1533 · DOI · Paper page
- Halicka, 1995, 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor, Cancer Res, 55, 444
- Geschwind, 2002, Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production, Cancer Res, 62, 3909
- Xu, 2005, Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia, Cancer Res, 65, 613, 10.1158/0008-5472.613.65.2 · DOI · Paper page
- Cao, 2007, Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia, Cancer Chemother Pharmacol, 59, 495, 10.1007/s00280-006-0291-9 · DOI · Paper page
- Adams, 2007, The Bcl-2 apoptotic switch in cancer development and therapy, Oncogene, 26, 1324, 10.1038/sj.onc.1210220 · DOI · Paper page
- Oltersdorf, 2005, An inhibitor of Bcl-2 family proteins induces regression of solid tumours, Nature, 435, 677, 10.1038/nature03579 · DOI · Paper page
- Huang, 2008, BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells, Cancer Res, 68, 2944, 10.1158/0008-5472.CAN-07-2508 · DOI
- Kang, 2007, Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo, Blood, 110, 2057, 10.1182/blood-2007-03-080325 · DOI
- Kuroda, 2008, ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms, Br J Haematol, 140, 181, 10.1111/j.1365-2141.2007.06899.x · DOI
- Vogler, 2008, A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells, Cell Death Differ, 15, 820, 10.1038/cdd.2008.25 · DOI
- Gogvadze, 2001, Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax, J Biol Chem, 276, 19066, 10.1074/jbc.M100614200 · DOI · Paper page
- Vogler M, Dinsdale D, Dyer MJ, Cohen GM. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ. 2008 Sep 19. [Epub ahead of print] PMID: 18806758. · DOI · Paper page
- Ponassi, 2008, A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity, Cell Cycle, 7, 3211, 10.4161/cc.7.20.6830 · doi:10.4161/cc.7.20.6830
- Lin, 2004, Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3, Cell, 116, 527, 10.1016/S0092-8674(04)00162-X · DOI · Paper page
- Kolluri, 2008, A short Nur77-derived peptide converts Bcl-2 from a protector to a killer, Cancer Cell, 14, 285, 10.1016/j.ccr.2008.09.002 · DOI · Paper page
- Wang, 2000, Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells, Proc Natl Acad Sci U S A, 97, 7124, 10.1073/pnas.97.13.7124 · DOI · Paper page
- Tzung, 2001, Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3, Nat Cell Biol, 3, 183, 10.1038/35055095 · DOI · Paper page
- Campas, 2006, Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells, Exp Hematol, 34, 1663, 10.1016/j.exphem.2006.07.008 · DOI
- Konopleva, 2008, Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax), Cancer Res, 68, 3413, 10.1158/0008-5472.CAN-07-1919 · DOI · Paper page
- Larochette, 1999, Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore, Exp Cell Res, 249, 413, 10.1006/excr.1999.4519 · DOI · Paper page
- Nutt, 2005, Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxide-induced apoptosis, Cancer Biol Ther, 4, 459, 10.4161/cbt.4.4.1652 · DOI
- Robertson, 2000, Distinct pathways for stimulation of cytochrome c release by etoposide, J Biol Chem, 275, 32438, 10.1074/jbc.C000518200 · DOI
- Pastorino, 2008, Regulation of hexokinase binding to VDAC, J Bioenerg Biomembr, 40, 171, 10.1007/s10863-008-9148-8 · DOI · Paper page
- Haridas, 2007, Avicins, a novel plant-derived metabolite lowers energy metabolism in tumor cells by targeting the outer mitochondrial membrane, Mitochondrion, 7, 234, 10.1016/j.mito.2006.12.005 · DOI
- Wolvetang, 1994, Mitochondrial respiratory chain inhibitors induce apoptosis, FEBS Lett, 339, 40, 10.1016/0014-5793(94)80380-3 · DOI · Paper page
- Asoh, 1996, Expression of the apoptosis-mediator Fas is enhanced by dysfunctional mitochondria, J Biochem, 120, 600, 10.1093/oxfordjournals.jbchem.a021455 · doi:10.1093/oxfordjournals.jbchem.a021455
- Xiao, 2008, Benzyl Isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells, J Biol Chem, 283, 30151, 10.1074/jbc.M802529200 · DOI · Paper page
- Chen, 2007, Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species, J Cell Sci, 120, 4155, 10.1242/jcs.011163 · DOI · Paper page
- Prasad, 1982, Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture, Cancer Res, 42, 550
- Qian, 1996, RRR-alpha-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells, Nutr Cancer, 25, 9, 10.1080/01635589609514424 · DOI
- Neuzil, 2001, Selective cancer cell killing by alpha-tocopheryl succinate, Br J Cancer, 84, 87, 10.1054/bjoc.2000.1559 · DOI · Paper page
- Weber, 2002, Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo, Clin Cancer Res, 8, 863
- Neuzil, 2007, Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II, J Bioenerg Biomembr, 39, 65, 10.1007/s10863-006-9060-z · DOI
- Neuzil, 2006, Molecular mechanism of ‘mitocan’-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins, FEBS Lett, 580, 5125, 10.1016/j.febslet.2006.05.072 · DOI · Paper page
- Yu, 2003, RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria, Cancer Res, 63, 2483
- Montero, 2008, Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma, Cancer Res, 68, 5246, 10.1158/0008-5472.CAN-07-6161 · DOI · Paper page
- Bonnet, 2007, A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth, Cancer Cell, 11, 37, 10.1016/j.ccr.2006.10.020 · DOI · Paper page
- Michelakis, 2008, Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer, Br J Cancer, 99, 989, 10.1038/sj.bjc.6604554 · DOI · Paper page
- Schulz, 2006, Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited, J Biol Chem, 281, 977, 10.1074/jbc.M511064200 · DOI · Paper page
- Polyak, 1997, A model for p53-induced apoptosis, Nature, 389, 300, 10.1038/38525 · DOI · Paper page
- Zhou, 2003, Mitochondrial impairment in p53-deficient human cancer cells, Mutagenesis, 18, 287, 10.1093/mutage/18.3.287 · DOI
- Nutt, 2005, Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2, Cell, 123, 89, 10.1016/j.cell.2005.07.032 · DOI · Paper page
- Marchenko, 2000, Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling, J Biol Chem, 275, 16202, 10.1074/jbc.275.21.16202 · DOI · Paper page
- Zache, 2008, PRIMA-1MET inhibits growth of mouse tumors carrying mutant p53, Cell Oncol, 30, 411
- Shen, 2008, PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2, Oncogene, 27, 6571, 10.1038/onc.2008.249 · DOI
- Wang, 2007, PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax, Biochem Biophys Res Commun, 352, 203, 10.1016/j.bbrc.2006.11.006 · DOI · Paper page
Cited by
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
Galluzzi, L., Bravo-San Pedro, J. M., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Alnemri, E. S., Altucci, L., Andrews, D., Annicchiarico-Petruzzelli, M., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.137 · Cited by 1,002
Self-citationMitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy
Yang, Y., Karakhanova, S., Hartwig, W., D'Haese, J. G., Philippov, P. P., Werner, J., & Bazhin, A. V. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25349 · Cited by 672
The chemistry, physiology and pathology of pH in cancer
Swietach, P., Vaughan-Jones, R. D., Harris, A. L., & Hulikova, A. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0099 · Cited by 539
Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications
Yousif, L. F., Stewart, K. M., & Kelley, S. O. (2009) · ChemBioChem · doi:10.1002/cbic.200900185 · Cited by 330
Metadata
- Authors
- Gogvadze, V., Orrenius, S., & Zhivotovsky, B.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 19
- Issue
- 1
- Pages
- 57-66
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2003959002
- Cited by
- 162
- References
- 15
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.